Serelaxin increases the antifibrotic action of rosiglitazone in a model of hepatic fibrosis

2017 
Serelaxin increases the antifibrotic action of rosiglitazone in a model of hepatic fibrosis
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    34
    References
    16
    Citations
    NaN
    KQI
    []